Botox, lasers, polynucleotides, exosomes, RF microneedling. Aesthetic medicine has never offered more options. But if I were building a 10-year plan for my own skin, I would start with strategy , not the treatment menu.
Botox, lasers, polynucleotides, exosomes, RF microneedling. Aesthetic medicine has never offered more options. But if I were building a 10-year plan for my own skin, I would start with strategy — not the treatment menu.
If I walked into an aesthetic clinic tomorrow, I wouldn't ask:
“What treatment should I get?”
I would ask:
“If I want my skin to look healthy, natural and age well over the next 10 years, what is the plan?”
Because aesthetics has become surprisingly similar to another world I know well: leadership and transformation.
When organizations face a problem, they often jump immediately to a solution.
New technology.
New structure.
New process.
New leadership program.
In aesthetics, we can do exactly the same thing.
New injectable.
New laser.
New device.
New regenerative treatment.
But a sophisticated solution applied to the wrong problem is still the wrong solution.
So if this were my face, my money and my next ten years, here is how I would think about it.
1. Diagnose before you treat
“I want to look younger” is not a diagnosis.
Is the issue pigmentation?
Texture?
Sun damage?
Dynamic wrinkles?
Loss of collagen?
Laxity?
Volume loss?
These are different problems. They shouldn't automatically receive the same treatment.
My first rule would therefore be:
Treat the problem, not the trend.
It sounds obvious.
So does “understand the business problem before reorganizing the company.”
Yet we don't always do either.
2. I would start with the boring things
Daily sun protection.
A sensible skincare routine.
And, when medically appropriate, evidence-based actives such as retinoids.
Why start there when aesthetic medicine can offer much more exciting interventions?
Because boring sometimes has very good evidence.
A recent meta-analysis of 8 randomized controlled trials involving 1,361 patients found that topical tretinoin significantly improved both fine and coarse facial wrinkles associated with photodamage.
Not glamorous.
Not new.
But useful.
Lesson #1: novelty and value are not the same thing.
That applies well beyond skincare.
3. I would invest in skin quality, not simply fewer wrinkles
My objective wouldn't be a face with no evidence of age.
I would want skin that looks:
healthy · even · resilient · firm · alive
Depending on the diagnosis, that might involve selected lasers, microneedling, RF microneedling or other collagen-remodeling approaches.
A 2026 systematic review of RF microneedling included 20 studies and 558 participants and found generally positive outcomes for facial rejuvenation, with reported adverse effects predominantly mild and temporary. Longer-term evidence remains more limited.
Would that mean I should automatically book RF microneedling?
No.
It means I have enough evidence to ask a better question:
“Is this the right intervention for my specific problem?”
4. I would be excited about regenerative aesthetics — and difficult to impress
Polynucleotides.
PRP.
Exosomes.
Biostimulators.
This is perhaps the most fascinating part of aesthetics today.
But I would separate two words very carefully:
PROMISING ≠ PROVEN
Take polynucleotides/PDRN.
A 2026 systematic review found only 7 randomized trials involving 183 participants, with just four focused on skin rejuvenation.
The findings were encouraging, but studies were small and protocols varied.
That's not a reason to dismiss the technology.
It's a reason to ask better questions.
Before putting a “regenerative” product into my face, I would want to know:
What exactly is the product?
What evidence exists for this indication?
What improvement should I realistically expect?
What are the risks?
How long should the result last?
What is the alternative?
And perhaps most importantly:
Why are you recommending this to me?
5. I would build a portfolio, not collect treatments
My long-term plan would probably look something like this:
PROTECT → CORRECT → STIMULATE → MEASURE → REASSESS
Not:
TREND → TREAT → TREND → TREAT → TREND
And I would deliberately add one more option:
DO NOTHING
I would trust a doctor more, not less, if sometimes the recommendation were:
“You don't need anything right now.”
There is an interesting leadership parallel here.
Good leaders don't prove their value by constantly intervening.
Good doctors shouldn't have to either.
Sometimes judgment is knowing what to do.
Sometimes it is knowing what not to do.
6. I would measure outcomes
Same lighting.
Same angle.
No makeup.
Standardized photographs before treatment and at meaningful intervals afterwards.
Because if I'm investing money, accepting risk and spending time recovering, I want to know whether the intervention actually produced a result.
Not whether the “after” photograph looks better.
This is another lesson organizations know surprisingly well but don't always practice:
If you cannot define the outcome, it becomes very easy to confuse activity with progress.
More treatments don't necessarily mean better skin.
Just as more initiatives don't necessarily mean a better organization.
What I would actually take into the consultation
I would have seven questions on my phone:
1. What exactly are we trying to improve?
2. Why this treatment?
3. What evidence supports it?
4. What result is realistic for me?
5. What are the risks and downtime?
6. How will we know whether it worked?
7. What happens if I do nothing?
That last question might be the most revealing of all.
Maybe aesthetics and leadership have more in common than I thought
Both are surrounded by new tools.
Both are vulnerable to trends.
Both reward intervention.
And in both, it can be tempting to mistake doing something for making something better.
The more options we have, the more important judgment becomes.
Diagnose before acting.
Choose the intervention that fits the problem.
Understand the evidence.
Measure the outcome.
Know when not to intervene.
That's good medicine.
It's also good leadership.
And if I were designing my own aesthetic plan, my goal wouldn't be to arrive at 50 or 60 trying desperately to look 35.
I'd want to arrive there looking like the healthiest, most natural version of myself at that age.
So perhaps the best question to ask in an aesthetic clinic isn't:
“What's the newest treatment?”
It's this:
“If this were your face, what would you do over the next 10 years — and what would you choose not to do?”
Because whether we're talking about a face or an organization, transformation without strategy can become just a collection of interventions.
And the best outcomes rarely come from doing the most.
They come from making better decisions.

Build. Lead. Grow.

Keep subscribing to SANDU DanielaHer next filing reaches you the moment it publishes, on her own subdomain.
Subscribe
